A Randomized, Double-blind, Placebo-controlled Trial Investigating the Effects of Levetiracetam in Early Psychosis
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Levetiracetam (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- 01 Feb 2018 Planned End Date changed from 30 May 2018 to 28 Feb 2019.
- 01 Feb 2018 Planned primary completion date changed from 1 Apr 2017 to 27 Feb 2019.
- 01 Feb 2018 Status changed from withdrawn prior to enrolment to recruiting.